CLINIGEN GROUP (LON:CLIN)

Founded in 2010, Clinigen Group PLC is a UK-based pharmaceutical company, which is partners with over 6,000 pharmacists and 250 pharmaceutical companies across the globe. The company was a merger of three companies: Clinigen Pharma, Clinigen Healthcare and Keats Healthcare. It is a part of the FTSE AIM 100.

The company’s aim is to deliver pharmaceutical products efficiently and in a secure manner, both for meeting medical needs of patients and for clinical studies across the world. The safe access to the right medicines at the right time can be decisive and crucial for patients. Therefore, the company takes full responsibility and utmost care of its operations because of the high stakes for the ultimate beneficiaries. The key priorities of the company are to maintain the quality of its products and provide the best customer service to its customers.

The company mainly focusses on management, sale, and distribution of pharmaceutical products. The company has five different segments to cover these operations:  Clinical Trial Services, Idis Managed Access, Idis Global Access, Specialty Pharmaceuticals, and Link Healthcare.

The Clinical Trial Services segment, or CTS, is involved in sourcing and distribution of medical products, like comparator drugs, adjuvant drugs and rescue therapies, for clinical studies and trials.

Idis Managed Access, or MA, is involved in consultancy, management, and implementation of managed access programmes across pharmaceutical and biotechnology-related companies. Idis Global Access, or GA, gives access to approved medicines with limited supply following an ethical process. Clinigen Specialty Pharmaceuticals, or SP, handles the manufacturing of its own and in-licensed specialist medicines, which are used in hospitals only. It also manages the distribution cycle across the world. The Link Healthcare is the segment which is involved in distribution of medicines and other pharmaceutical products in Asia- Pacific region and South Africa.

The company has well-defined standards of corporate governance and complies with the UK Corporate Governance Code. It follows an ethical business code of conduct. It has an ESG frameworks and fulfils its environmental and social responsibilities as committed. It aligns itself with the UN Sustainable Development Goals as a responsible global pharmaceutical company and strives for environment friendly business solutions.